82 related articles for article (PubMed ID: 19813148)
1. Ganglioglioma associated with alterations of NBN gene. A case report.
Grajkowska W; Piekutowska-Abramczuk D; Ciara E; Dembowska-Baginska B; Perek D; Roszkowski M; Daszkiewicz P; Matyja E; Pronicki M; Chrzanowska KH
Folia Neuropathol; 2009; 47(3):278-83. PubMed ID: 19813148
[TBL] [Abstract][Full Text] [Related]
2. The reelin pathway components disabled-1 and p35 in gangliogliomas--a mutation and expression analysis.
Kam R; Chen J; Blümcke I; Normann S; Fassunke J; Elger CE; Schramm J; Wiestler OD; Becker AJ
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):225-32. PubMed ID: 15175076
[TBL] [Abstract][Full Text] [Related]
3. Glioblastomatous transformation of ganglioglioma: case report with reference to molecular genetic and flow cytometric analysis.
Kim NR; Wang KC; Bang JS; Choe G; Park Y; Kim SK; Cho BK; Chi JG
Pathol Int; 2003 Dec; 53(12):874-82. PubMed ID: 14629754
[TBL] [Abstract][Full Text] [Related]
4. Suprasellar ganglioglioma with unusual diffuse involvement of the entire optico-chiasmal hypothalamic pathway.
Jalali R; Deopujari CE; Bhutani R; Suhas U; Rajasekharan P; Kane SV; Gupta T
J Cancer Res Ther; 2008; 4(3):140-3. PubMed ID: 18923209
[TBL] [Abstract][Full Text] [Related]
5. Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implications.
Resta N; Lauriola L; Puca A; Susca FC; Albanese A; Sabatino G; Di Giacomo MC; Gessi M; Guanti G
Acta Neuropathol; 2006 Jul; 112(1):106-11. PubMed ID: 16733653
[TBL] [Abstract][Full Text] [Related]
6. Primary anaplastic ganglioglioma with a small-cell glioblastoma component.
Schittenhelm J; Reifenberger G; Ritz R; Nägele T; Weller M; Pantazis G; Capper D; Beschorner R; Meyermann R; Mittelbronn M
Clin Neuropathol; 2008; 27(2):91-5. PubMed ID: 18402388
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic features in anaplastic ganglioglioma: analysis of cases from the SEER database.
Selvanathan SK; Hammouche S; Salminen HJ; Jenkinson MD
J Neurooncol; 2011 Dec; 105(3):539-45. PubMed ID: 21626070
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report.
Hayashi Y; Iwato M; Hasegawa M; Tachibana O; von Deimling A; Yamashita J
J Neurosurg; 2001 Jul; 95(1):138-42. PubMed ID: 11453385
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics.
Kros JM; Delwel EJ; de Jong TH; Tanghe HL; van Run PR; Vissers K; Alers JC
Acta Neuropathol; 2002 Aug; 104(2):144-8. PubMed ID: 12111357
[TBL] [Abstract][Full Text] [Related]
10. Unprecedented response to combination BRAF and MEK inhibitors in adult anaplastic ganglioglioma.
Beland B; Tsang RY; Sutherland G
J Neurooncol; 2018 May; 137(3):667-669. PubMed ID: 29335912
[No Abstract] [Full Text] [Related]
11. Molecular genetic analysis in a case of ganglioglioma: identification of a new mutation.
De Tommasi A; Luzzi S; D'Urso PI; De Tommasi C; Resta N; Ciappetta P
Neurosurgery; 2008 Nov; 63(5):976-80; discussion 980. PubMed ID: 19005389
[TBL] [Abstract][Full Text] [Related]
12. Multicentric hemispheric ganglioglioma in a 20-year-old adult.
Ma SP; Tsui A; Kaye AH
J Clin Neurosci; 2015 Feb; 22(2):418-20. PubMed ID: 25304433
[TBL] [Abstract][Full Text] [Related]
13. Pediatric primary anaplastic ganglioglioma with malignant neuronal component.
Kaymak-Cihan M; Erdiş E; Bozkurt S; Ünver-Korğalı E
Turk J Pediatr; 2018; 60(1):102-106. PubMed ID: 30102489
[TBL] [Abstract][Full Text] [Related]
14. Oligodendroglial ganglioglioma.
Yamashita S; Yokogami K; Niibo T; Takeishi G; Ikeda T; Miyata S; Uehara H; Fukushima T; Nakazato Y; Takeshima H
Brain Tumor Pathol; 2011 Oct; 28(4):311-6. PubMed ID: 21725645
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations in a papillary glioneuronal tumor.
Faria C; Miguéns J; Antunes JL; Barroso C; Pimentel J; Martins Mdo C; Moura-Nunes V; Roque L
J Neurosurg Pediatr; 2008 Jan; 1(1):99-102. PubMed ID: 18352813
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic ganglioglioma with sarcomatous component: an immunohistochemical study and molecular analysis of p53 tumor suppressor gene.
Suzuki H; Otsuki T; Iwasaki Y; Katakura R; Asano H; Tadokoro M; Suzuki Y; Tezuka F; Takei H
Neuropathology; 2002 Mar; 22(1):40-7. PubMed ID: 12030414
[TBL] [Abstract][Full Text] [Related]
17. Malignant and benign ganglioglioma: a pathological and molecular study.
Pandita A; Balasubramaniam A; Perrin R; Shannon P; Guha A
Neuro Oncol; 2007 Apr; 9(2):124-34. PubMed ID: 17259542
[TBL] [Abstract][Full Text] [Related]
18. Aberrant TP53 protein accumulation in the neuronal component of ganglioglioma.
Fukushima T; Katayama Y; Watanabe T; Yoshino A; Komine C; Yokoyama T
J Neurooncol; 2005 Apr; 72(2):103-6. PubMed ID: 15925988
[TBL] [Abstract][Full Text] [Related]
19. Ganglioglioma in a Sotos syndrome patient with an NSD1 deletion.
Deardorff MA; Maisenbacher M; Zackai EH
Am J Med Genet A; 2004 Nov; 130A(4):393-4. PubMed ID: 15455365
[TBL] [Abstract][Full Text] [Related]
20. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
